Outcome after endoscopic treatment for dysplasia and superficial esophageal cancer – a cohort study

References

• Schlottmann F, Patti MG. Current concepts in treatment of Barrett's esophagus with and without dysplasia. J Gastrointest Surg. 2017;21(8):1354–1360.
   PubMed Web of Science ®Google Scholar
• Qumseya BJ, Wani S, Gendy S, et al. Disease progression in Barrett's low-grade dysplasia with radiofrequency ablation compared with surveillance: systematic review and meta-analysis. Am J Gastroenterol. 2017;112:849–865.
   PubMed Web of Science ®Google Scholar
• Phoa KN, van Vilsteren FG, Weusten BL, et al. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA. 2014;311(12):1209–1217.
   PubMed Web of Science ®Google Scholar
• Pouw RE, Klaver E, Phoa KN, et al. Radiofrequency ablation for low-grade dysplasia  in Barrett's esophagus: long-term outcome of a randomized trial. Gastrointest Endosc. 2020. In Press. DOI:10.1016/j.gie.2020.03.3756
   Web of Science ®Google Scholar
• Helsedirektoratet. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av spiserørskreft (5th ed.). Available from: www.helsedirektoratet.no
   Google Scholar
• Weusten B, Bisschops R, Coron E, et al. Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy. 2017;49(2):191–198.
   PubMed Web of Science ®Google Scholar
• Inoue H, Endo M. Endoscopic esophageal mucosal resection using a transparent tube. Surg Endosc. 1990;4(4):198–201.
   PubMed Web of Science ®Google Scholar
• Pech O, May A, Manner H, et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology. 2014;146(3):652–660.
   PubMed Web of Science ®Google Scholar
• Old OJ, Almond LM, Barr H. Barrett's oesophagus: how should we manage it? Frontline Gastroenterol. 2015;6(2):108–116.
   PubMed Web of Science ®Google Scholar
• World Health Organization. International statistical classification of diseases and related health problems. Geneva, Switzerland: World Health Organization; 1992.
   Google Scholar
• Sobin LG, Wittekind C. TNM classification of malignant tumours. 7th ed. Oxford (UK): Wiley-Blackwell; 2009.
   Google Scholar
• Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology. 2006;131(5):1392–1399.
   PubMed Web of Science ®Google Scholar
• Levine DS, Blount PL, Rudolph RE, et al. Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus. Am J Gastroenterol. 2000;95(5):1152–1157.
   PubMed Web of Science ®Google Scholar
• Japan Esophageal S. Japanese classification of esophageal cancer, 11th edition: part I. Esophagus. 2017;14:1–36.
   PubMed Web of Science ®Google Scholar
• Belghazi K, Schölvinck DW, van Berge Henegouwen MI, et al. Results of a two-phased clinical study evaluating a new multiband mucosectomy device for early Barrett's neoplasia: a randomized pre-esophagectomy trial and a pilot therapeutic pilot study. Surg Endosc. 2019;33(9):2864–2872.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. Common Terminology Criteria for Adverse Events (CTCAE). 4.03 ed. National Institutes of Health; 2010. Available from: https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm
   Google Scholar
• Ogilvie AL, Dronfield MW, Ferguson R, et al. Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy. Gut. 1982;23(12):1060–1067.
   PubMed Web of Science ®Google Scholar
• Bjordal K, de Graeff A, Fayers PM, et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer. 2000;36(14):1796–1807.
   PubMed Web of Science ®Google Scholar
• Lagergren P, Fayers P, Conroy T, et al. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach. Eur J Cancer. 2007;43(14):2066–2073.
   PubMed Web of Science ®Google Scholar
• Hinz A, Singer S, Brahler E. European reference values for the quality of life questionnaire EORTC QLQ-C30: results of a German investigation and a summarizing analysis of six European general population normative studies. Acta Oncol. 2014;53(7):958–965.
   PubMed Web of Science ®Google Scholar
• Konda VJ, Gonzalez Haba Ruiz M, Koons A, et al. Complete endoscopic mucosal resection is effective and durable treatment for Barrett's-associated neoplasia. Clin Gastroenterol Hepatol. 2014;12(12):2002–2010.
   PubMed Web of Science ®Google Scholar
• Larghi A, Lightdale CJ, Ross AS, et al. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy. 2007;39(12):1086–1091.
   PubMed Web of Science ®Google Scholar
• Chennat J, Konda VJ, Ross AS, et al. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma-an American single-center experience. Am J Gastroenterol. 2009;104(11):2684–2692.
   PubMed Web of Science ®Google Scholar
• Schwameis K, Zehetner J, Green KM, et al. Workload, recurrence, quality of life and long-term efficacy of endoscopic therapy for high-grade dysplasia and intramucosal esophageal adenocarcinoma. Ann Surg. 2020;271(4):701–708.
   PubMed Web of Science ®Google Scholar
• Rosmolen WD, Nieuwkerk PT, Pouw RE, et al. Quality of life and fear of cancer recurrence after endoscopic treatment for early Barrett's neoplasia: a prospective study. Dis Esophagus. 2017;30:1–9.
   PubMed Web of Science ®Google Scholar